Liberty One Investment Management LLC raised its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 5.6% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 55,240 shares of the company’s stock after buying an additional 2,912 shares during the quarter. Liberty One Investment Management LLC’s holdings in Colgate-Palmolive were worth $5,022,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Peak Financial Advisors LLC acquired a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $1,315,000. Gordian Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $602,000. Carrera Capital Advisors boosted its position in shares of Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares in the last quarter. Vontobel Holding Ltd. grew its stake in Colgate-Palmolive by 224.6% during the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after buying an additional 550,750 shares during the last quarter. Finally, Fiduciary Alliance LLC acquired a new position in Colgate-Palmolive during the 4th quarter valued at about $4,066,000. 80.41% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
CL has been the subject of several recent analyst reports. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research note on Friday. Piper Sandler cut their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. UBS Group lowered their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday. Finally, TD Cowen cut their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus target price of $101.11.
Colgate-Palmolive Trading Up 0.3 %
Colgate-Palmolive stock opened at $88.79 on Friday. The firm has a market cap of $72.55 billion, a PE ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a 12 month low of $79.69 and a 12 month high of $109.30. The stock’s 50 day simple moving average is $92.20 and its two-hundred day simple moving average is $97.74. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.
Colgate-Palmolive Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.
Insider Activity at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.37% of the stock is owned by company insiders.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- What is the Nasdaq? Complete Overview with History
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- What is a Stock Market Index and How Do You Use Them?
- Oilfield Leader SLB: An AI Name You Need to Know
- The 3 Best Blue-Chip Stocks to Buy Now
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.